跳至主要内容
临床试验/IRCT20170609034406N10
IRCT20170609034406N10尚未招募2 期

The potential effect of parenteral L-carnitine on hospitalized patients with moderate to severe COVID-19

Tabriz University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • adults aged 18 years or older
  • Positive PCR test for COVID-19
  • Patients with moderate to severe disease
  • Signs and Symptoms compatible with COVID-19 disease according to the Iranian Ministry of Health protocol
  • Prior to the fifth day of symptoms onset

排除标准

  • HIV Infection
  • History of taking L-carnitine supplement in the recent Month
  • known immunosuppression condition or any active malignancy
  • Patients with hypothyroidism or hyperthyroidism
  • patients with regular aerobic training (more than 3 times a week with further than 2 hours each time)
  • History of allergy to L-carnitine or its analogues
  • History of or an increased risk for seizure

研究者

相似试验